A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.
about
Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case ReportA fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responsesCurrent and emerging treatment options for interstitial lung disease in patients with rheumatic disease.Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?False Positive B-Cells Crossmatch after Prior Rituximab Exposure of the Kidney Donor.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice.
P2860
Q33698000-5C31DA42-9207-403A-BB11-F2C38FF60E7FQ37010668-F5CBC5E5-23FA-4356-B19C-F05223C6FD52Q38692232-5DE90844-6D4B-471D-A3DF-397D974F4759Q38728585-53BCF1D5-F418-4749-9DBD-99F490D48F1EQ41446140-2C502B0E-D950-4C43-9180-59F10D32DDBEQ42372842-9624473C-746A-4F43-ABE9-AB84B54BFA22Q49395392-3FE0120C-DD9F-43BC-9286-96DBD475229F
P2860
A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A review of rituximab, the fir ...... of B non-Hodgkin's lymphomas.
@en
type
label
A review of rituximab, the fir ...... of B non-Hodgkin's lymphomas.
@en
prefLabel
A review of rituximab, the fir ...... of B non-Hodgkin's lymphomas.
@en
P2860
P356
P1433
P1476
A review of rituximab, the fir ...... of B non-Hodgkin's lymphomas.
@en
P2093
Pierre Feugier
P2860
P304
P356
10.2217/FON.15.57
P407
P577
2015-01-01T00:00:00Z